Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Social Psychiatry and Psychiatric Epidemiology
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 4/2008

01.04.2008 | ORIGINAL PAPER

Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population

verfasst von: Dr. Lydia Fehm, Katja Beesdo, Frank Jacobi, Agnes Fiedler

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

There is a lack of data systematically describing subthreshold expressions of social anxiety disorder (SAD) with regard to prevalence, comorbidity, and impairment.

Methods

This analysis was based on data from the German Health Survey (GHS) and its Mental Health Supplement (GHS-MHS). Social anxiety disorder and its syndromes as well as other mental disorders were assessed with a standardized diagnostic interview (M-CIDI) in 4,174 adults.

Results

The 12-month prevalence rate for threshold SAD was 2.0%, subthreshold and symptomatic social anxiety (one DSM-IV criterion missing/two or more criteria missing) was found in 3.0 and 7.5% of the participants, respectively. As expected, threshold SAD was characterized by an elevated risk for comorbid disorders and associated with impairment in diverse areas of life. However, this was also true for the two subthreshold expressions of social anxiety, which were also significantly associated with higher comorbidity and greater impairment compared to the control group.

Conclusions

Our results suggest that social anxiety below the diagnostic threshold is clearly associated with adverse outcomes. Prospective designs should examine the exact temporal and possible causal pathways of this burden in order to inform prevention and early intervention programs.
Literatur
1.
APA (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2.
Baumeister H, Harter M (2007) Prevalence of mental disorders based on general population surveys. Soc Psychiatry Psychiatr Epidemiol 42(7):537–546PubMedCrossRef
3.
Beals J et al. (2004) Challenges in operationalizing the DSM-IV clinical significance criterion. Arch Gen Psychiatry 61(12):1197–1207PubMedCrossRef
4.
Beesdo K et al. (2007) Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 64(8):1–10CrossRef
5.
Bellach B-M, Knopf H, Thefeld W (1998) Der Bundes-Gesundheitssurvey 1997/1998. Das Gesundheitswesen 60:59–68
6.
Bittner A et al. (2004) What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 65(5):618–626PubMedCrossRef
7.
Brazier JE et al. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 305:160–164
8.
Bruce SE et al. (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162(6):1179–1187PubMedCrossRef
9.
Davidson JRT et al. (1993) The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 23:709–718PubMedCrossRef
10.
Davidson JRT et al. (1994) The boundary of social phobia—exploring the threshold. Arch Gen Psychiatry 51(12):975–983PubMed
11.
DeWit DJ et al. (1999) Antecedents of the risk of recovery from DSM-III-R social phobia. Psychol Med 29:569–582PubMedCrossRef
12.
Degonda M, Angst J (1993) The Zurich Study XX. Social phobia and agoraphobia. Eur Arch Psychiatry Clin Neurosci 243:95–102PubMedCrossRef
13.
Eng W et al. (2005) Domains of life satisfaction in social anxiety disorder: relation to symptoms and response to cognitive-behavioral therapy. J Anxiety Disord 19:143–156PubMedCrossRef
14.
Escobar JI et al. (1989) Somatic symptom index (SSI)—a new and abridged somatization construct—prevalence and epidemiological correlates in 2 large community samples. J Nerv Ment Dis 177(3):140–146PubMedCrossRef
15.
Faravelli C et al. (2000) Epidemiology of social phobia: a clinical approach. Eur Psychiatry 15:17–24PubMedCrossRef
16.
Fehm L et al. (2005) Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 15:453–462PubMedCrossRef
17.
Fehm L, Wittchen H-U (2004) Comorbidity in social anxiety disorder. In: Bandelow B, Stein D (eds) Social anxiety disorder. Dekker, New York, pp 49–63
18.
de Graaf R et al. (2003) Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders. Findings from the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol 38:p1–p11CrossRef
19.
Jacobi F et al. (2002) Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res 11(1):1–18PubMedCrossRef
20.
Jacobi F et al. (2004) Prevalence, comorbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 34(4):597–611PubMedCrossRef
21.
Kessler RC et al. (1999) Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol Med 29:555–567PubMedCrossRef
22.
Kessler RC et al. (2003) Mild disorders should not be eliminated from the DSM-V. Arch Gen Psychiatry 60(11):1117–1122PubMedCrossRef
23.
Kessler RC et al. (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617–627PubMedCrossRef
24.
Kessler RC et al. (2005) Lifetime prevalence and age-of-onset distributions’ of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):593–602PubMedCrossRef
25.
Knauper B, Wittchen HU (1994) Diagnosing major depression in the elderly—evidence for response bias in standardized diagnostic interviews. J Psychiatr Res 28(2):147–164PubMedCrossRef
26.
Lochner C et al. (2003) Quality of life in anxiety disorders: a comparison of obsessive–compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology 36(5):255–262PubMedCrossRef
27.
Mendlowicz MV, Stein MB (2000) Quality of life in individuals with anxiety disorders. Am J Psychiatry 157(5):669–682PubMedCrossRef
28.
Merikangas KR et al. (2002) The spectrum of social phobia in the Zurich Cohort Study of young adults. Biol Psychiatry 51(1):81–91PubMedCrossRef
29.
Meyer C et al. (2000) Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung - Ergebnisse der TACOS-Studie [Lifetime prevalence of mental disorders in the adult general population: Findings from the TACOS study]. Nervenarzt 71:535–542PubMedCrossRef
30.
Meyer C et al. (2004) Impact of psychiatric disorders in the general population: satisfaction with life and the influence of comorbidity and disorder duration. Soc Psychiatry Psychiatr Epidemiol 39:435–441PubMedCrossRef
31.
Müller N (2002) Die soziale Angststörung bei Jugendlichen und jungen Erwachsenen: Erscheinungsformen, Verlauf und Konsequenzen, Münster, Waxmann
32.
Quilty LC et al. (2003) Quality of life and the anxiety disorders. Anxiety Disord 17:405–426CrossRef
33.
Reed V et al. (1998) To what degree the Composite International Diagnostic Interview (CIDI) correctly identifies DSM-IV disorders? Testing validity issues in a clinical sample. Int J Methods Psychiatr Res 7:142–155CrossRef
34.
Schatzberg AF et al. (1998) McLean Hospital Depression Research Facility: early-onset phobic disorders and adult-onset major depression. Br J Psychiatry 173(suppl 34):29–34
35.
Schneier FR et al. (1992) Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49:282–288PubMed
36.
Schneier FR (2003) Social anxiety disorder—is common, underdiagnosed, impairing, and treatable. Br Med J 327(7414):515–516CrossRef
37.
Stein MB et al. (2001) Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Arch Gen Psychiatry 58:251–256PubMedCrossRef
38.
Turk CL et al. (1998) An investigation of gender differences in social phobia. J Anxiety Disord 12:209–223PubMedCrossRef
39.
Van Ameringen M et al. (1991) Relationships of social phobia with other psychiatric illness. J Affect Disord 21:93–99PubMedCrossRef
40.
Von Zerssen D, Koeller DM (1976) B-L Beschwerden-Liste. Klinische Selbstbeurteilungs-Skalen (KSB-S) aus dem Münchener Psychiatrischen Informations-System (PSYCHIS München). Beltz, Weinheim
41.
WHO (1997) Composite International Diagnostic Interview (CIDI, Version 2.1). World Health Organization, Geneva
42.
Wang PS et al. (2005) Failure and delay in initial treatment contact after first onset of mental disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):603–613PubMedCrossRef
43.
Weiller E et al. (1996) Social phobia in general health care: an unrecognised undertreated disabling disorder. Br J Psychiatry 168:169–174PubMedCrossRef
44.
Weinstock LS (1999) Gender differences in the presentation and management of social anxiety disorder. J Clin Psychiatry 60(suppl 9):9–13PubMed
45.
Wittchen HU (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. Int J Psychiatr Res 28:57–84CrossRef
46.
Wittchen HU et al. (1998) Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33(11):568–578PubMedCrossRef
47.
Wittchen H-U et al. (1999) Affektive, somatoforme und Angststörungen in Deutschland - Erste Ergebnisse des bundesweiten Zusatzsurveys “Psychische Störungen”. Gesundheitswesen Sonderheft 2:S216–S222
48.
Wittchen H-U et al. (2000) Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. Eur Psychiatry 15(1):46–58PubMedCrossRef
49.
Wittchen H-U, Pfister H (eds) (1997) DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft für Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittsuntersuchung (DIA-X-Monate); Ergänzungsheft (DIA-X-Monate); PC-Programm zur Durchführung des Interviews (Längs- und Querschnittsuntersuchung); Auswertungsprogramm. Frankfurt, Swets and Zeitlinger
50.
Wittchen H-U, Stein MB, Kessler RC (1999) Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity. Psychol Med 29:309–323PubMedCrossRef
Metadaten
Titel
Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population
verfasst von
Dr. Lydia Fehm
Katja Beesdo
Frank Jacobi
Agnes Fiedler
Publikationsdatum
01.04.2008
Verlag
D. Steinkopff-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 4/2008
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-007-0299-4

Weitere Artikel der Ausgabe 4/2008

Social Psychiatry and Psychiatric Epidemiology 4/2008 Zur Ausgabe

ORIGINAL PAPER

Recent trends in UK child and adolescent mental health

ORIGINAL PAPER

Lay beliefs regarding causes of mental illness in Nigeria: pattern and correlates

ORIGINAL PAPER

Rural−urban differences in Austrian suicides

ORIGINAL PAPER

Social phobia and number of social fears, and their association with comorbidity, health-related quality of life and help seeking

ORIGINAL PAPER

Adverse parenting as a risk factor in the occurrence of anxiety disorders

ORIGINAL PAPER

Attitudes towards suicide among Kurdish people in Iran

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise